News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Conference News SCAI 2022 DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year L.A. McKeown May 23, 2022
News Conference News SCAI 2022 SAFE-PAD Provides More Long-term Safety Data for Paclitaxel L.A. McKeown May 22, 2022
News Conference News SCAI 2021 Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year Yael L. Maxwell May 04, 2021
News Conference News SCAI 2021 Chinese Registry Supports Prolonged DAPT Following PCI for ACS Yael L. Maxwell May 03, 2021
News Conference News SCAI 2020 Late and Early Results in Tune for Melody and Harmony Transcatheter PVs Caitlin E. Cox May 25, 2020
News Conference News SCAI 2019 LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER Yael L. Maxwell June 03, 2019
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Conference News SCAI 2017 Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It L.A. McKeown May 19, 2017
News Conference News SCAI 2013 Live TAVR Cases Pose No Additional Risk for Patients L.A. McKeown May 10, 2013